- L.J., a 70-year-old retired bus driver, was admitted with right deep vein thrombosis (DVT). He has a history of smoking, pneumonia, atrial fibrillation, and previous DVTs.
- He reported swelling in his right leg that progressed over two months. A Doppler study confirmed a thrombus in his right leg vein.
- He was admitted to begin treatment with bed rest, heparin therapy, and monitoring to prevent pulmonary embolism complications.
Original Description:
Cardiovascular disorders: Deep Vein Thrombosis Case Study
- L.J., a 70-year-old retired bus driver, was admitted with right deep vein thrombosis (DVT). He has a history of smoking, pneumonia, atrial fibrillation, and previous DVTs.
- He reported swelling in his right leg that progressed over two months. A Doppler study confirmed a thrombus in his right leg vein.
- He was admitted to begin treatment with bed rest, heparin therapy, and monitoring to prevent pulmonary embolism complications.
- L.J., a 70-year-old retired bus driver, was admitted with right deep vein thrombosis (DVT). He has a history of smoking, pneumonia, atrial fibrillation, and previous DVTs.
- He reported swelling in his right leg that progressed over two months. A Doppler study confirmed a thrombus in his right leg vein.
- He was admitted to begin treatment with bed rest, heparin therapy, and monitoring to prevent pulmonary embolism complications.
- L.J., 70 y/o retired bus driver admitted with Right DVT
- Has 48 pack year smoking history, quitted 2 years ago - Has had pneumonia several times and frequent episodes of A-fib - 2 previous episodes of DVT and was diagnosed with rheumoid arthritis 3 years ago - HPI: 2 mos ago he began experiencing SOB on exertion and noticed swelling of his R foreleg that became progressively worse until it involved his thigh to the groin - SO: wife, who brought LJ to the hospital when he c/o increasingly severe pain in his leg - Doppler study indicated a probable thrombus vein extending distally to the lower leg - Admitted for bed rest and to initiate heparin therapy - Lab values : PT 12.4, INR 1.11, PTT 25 sec, Hgb 13.3 g/dl Hct 38.9, cholesterol 206 mg/dl. BMP is normal Deep Vein Thrombosis description A blood clot (thrombus) that forms inside a deep vein. It may partially or completely block blood flow, or it could break off and travel to the lung. Deep vein thrombosis often occurs in the lower legs (calves). Less often it occurs in the arm or pelvis. causes Pooling of blood in the vein, which triggers blood-clotting mechanisms. The pooling may occur after prolonged bed rest, following surgery, or from long-lasting illness, such as heart attack, stroke, or bone fracture. risk increases with Persons over 60. Obesity. Smoking. Surgery and surgery recovery. Cancer, heart failure, stroke, and polycythemia. Bed rest for an extended time, burns, or injuries. Blood disorders that increase the risk of blood clots. Signs and Symptoms Oedema Calf pain Tenderness Swelling Increased skin temperature Engorgement of superficial leg veins Slight fever Positive Homans sign (discomfort in calf muscles on forced dorsiflexion Initial assessment by observation and examination
Observation Observe and record skin colour. Compare with unaffected side. Is the area swollen? Compare with unaffected side. Is oedema present? Is the area painful? Check for pain at rest or on movement. Is the area reddened? Compare with unaffected side. Are any wounds present? If so, how long have they been present? Have they been treated? By whom?
Physical examination Check and record presence of distal pulses on the affected limb and compare with the unaffected side. Check and record heart rate, respiratory rate and depth, blood pressure and temperature. Is the area hot? Compare with unaffected side. Palpate the area for pain or tenderness. Compare with the unaffected side. Check for range of movement of proximal and distal joints. Does this increase pain? Can the patient walk normally on the affected limb(s)? Information to be collected during history taking Information to be collected verbally History of present problem: How long has it been present? When did it start? Is it constant or intermittent? Is it worse today than usual? Is there any previous history of same or similar problem? Is there any recent history of injury to the affected area? Has there been any recent long distance travel (>4 hours) in last 4 weeks? Has there been any previous surgery especially orthopaedic, pelvic or abdominal? Is the area painful? If so, does anything relieve the pain or make it worse? Has any medication been taken to relieve the problem?
Immediate management and investigations Patients with suspected DVT are nursed on a stretcher-trolley, in a bed or in a chair. Elevate the affected leg with some flexion of the knee (to encourage venous drainage) and support it on a pillow in the position most comfortable for the patient. Take a history (Boxes 11.2 and 11.3), measure vital signs, gain intravenous (IV) access and take bloods for full blood count (FBC), urea, electrolytes and clotting screen. In addition, oxygen saturation may be measured and oxygen given if required. Measurement of calf circumferences to provide a baseline for further evaluation may be carried out 10 cm below the tibial tuberosity. A swelling of 3 cm greater than the asymptomatic side is a relative indicator of DVT but is not definitive. Application of graded compression stockings can reduce postthrombotic syndrome by up to 60% (Gorman et al 2000). Explain procedures to the patient and assess their potential for early discharge. The principle of managing patients with a DVT is early initiation of effective anticoagulant therapy with the aim of preventing further progression of the thrombosis to the proximal veins and, thereby, pulmonary embolism. Given that diagnosis on the basis of clinical features is often inconclusive, management of suspected DVT is based on the results obtained from one or more objective diagnostic investigations. To support this, clinical risk factors (Box 11.1) are also assessed and taken into account, as confirmation rates of DVT rise with the number of factors present. Identification of an underlying cause, if present, will also guide the treatment and prevention of further episodes (Gorman et al 2000). The standard radiographic investigation for DVT is contrast venography (Gorman et al 2000) but the painful, invasive nature of this procedure, its technical difficulty and the time taken for completion make it inappropriate for use in acute settings. Technological advances in recent years have led to the introduction of non-invasive ultrasonography as a first-line investigation for DVTs. Known as pulsed Doppler ultrasound, this technique measures the velocity of moving objects (such as red blood cells) in comparison to other objects. Rapid, effective anticoagulant therapy is important in the initial management of DVT. Treatment usually starts with an intravenous dose of heparin (5000 units) followed by subcutaneous low molecular weight heparin (LMWH) for 5 days. LMWH has been shown to be at least as effective as the traditionally used unfractionated heparin in preventing recurrent venous thromboembolism. In addition, it significantly reduces the occurrence of major haemorrhage during initial treatment and reduces overall mortality at the end of the patients follow-up period (van den Belt et al 2000). Oral warfarin is usually started on day 1 with the dose determined by algorithm.
The Wells clinical prediction guide for DVT (Anand et al 1998) Clinical feature Score Active cancer (treatment ongoing or within 6 months or palliative) 1 Paralysis, paresis or plaster of Paris on lower leg 1 Recently bedridden >3 days or major surgery within 4 weeks 1 Localised tenderness along distribution of deep vein system 1 Calf diameter >3 cm larger than the asymptomatic leg* 1 Pitting oedema 1 Entire swollen leg 1 Collateral superficial veins (non-varicose) 1 Alternative diagnosis (as likely or greater than that of DVT) 2 Adding the scores with a total as follows indicates probability of DVT: 0 = low probability = 3% frequency of DVT 12 = medium probability = 17% frequency of DVT 3+ = high probability = 75% frequency of DVT *Measured 10 cm below tibial tuberosity Ongoing assessment and treatment Gorman et al (2000) suggest that the patients activated partial thromboplastin time (aPTT) is checked every 6 hours until the target of 1.52.5 is reached or according to a heparin algorithm. Once reached, this should be checked daily to maintain this range. Platelet count should also be measured at the start of treatment and on day 5 to rule out thrombocytopenia. Duration of treatment for DVT varies from 3 to 12 months depending upon the risk of recurrence of thrombosis. Many patients who are referred with DVT can be discharged once initial investigations and treatment have been completed. Pout et al (1999) give an example of how a nurse-led outpatient clinic has successfully been introduced to treat patients with daily doses of LMWH. This approach has been adopted in other centres with the aim of improving the service to patients and relieving pressure on individual MAUs
COMPLICATION Pulmonary Embolism 2. Symptoms: dyspnea (73%), pleuritic pain (66%), cough (37%), leg pain or swelling (27%), hemoptysis (13%), lightheadedness, loss of consciousness.
4. Work-up: Always think of PE in patients with new or unexplained dyspnea and/or hypoxemia. Studies should include: CXR: abnormal in 84% but non-specific: atelectasis, effusion, basilar opacity, elevated diaphragm, Westermarks sign (focal decreased pulmonary vessel perfusion), Hamptons hump (peripheral wedge shaped density). ECG: sinus tachycardia, S1Q3T3, right axis-deviation, RBBB, T wave inversions of V1-4, a-fib/flutter. ABG: mean PaO2 70mmHg, < 60 (25%), < 80 (74%). Normal ABG does not rule out PE if clinical suspicion high. D-Dimer: if ELISA test available, a low result has an extremely high negative predictive value. Spiral CT, V/Q Scan, LE doppler ultrasound. Echo can be useful in massive PE.
Treatment Unfractionated heparin: Low molecular weight heparin (enoxaparin): preferred treatment for ease of use; dose at 1mg/kg q12h SQ. Continue for ~5 days, until INR is therapeutic (2.0-3.0) on warfarin. Relative contraindication if CrCl < 30 ml/min or weight > 120 kg. Can follow anti-factor Xa levels if available.
Warfarin: start when patient is stable (which may be on admission).
Thrombolytics: consider in massive PE with hemodynamic compromise (call pulmonary consult). Stop heparin and dose tPA at 100 mg IV over 2 hours. Can use up to 14 days after initial onset of PE. Obtain consent, review exclusion criteria, monitor frequently for neuro changes, and know full tPA protocol if you are going to proceed to thrombolysis.
IVC filter: in patients who develop PE while anticoagulated, or in patients in whom anticoagulation is contraindicated (recent surgery, CVA). Not effective as long-term treatment.
Start hypercoagulability workup when appropriate (i.e., when common risk factors are absent).